Differing Effects of Zoledronic Acid on Bone Microarchitecture and Bone Mineral Density in Men Receiving Androgen Deprivation Therapy: A Randomized Controlled Trial

A Randomized Trial of Zoledronic Acid to Prevent Bone Loss in the First Year after Kidney Transplantation

(2019) Igor Denizarde Bacelar Marques et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Antiresorptive and anabolic agents in the prevention and reversal of bone fragility

(2019) Ego Seeman et al.   Nature Reviews Rheumatology

Cortical and trabecular bone microarchitecture as an independent predictor of incident fracture risk in older women and men in the Bone Microarchitecture International Consortium (BoMIC): a prospective study

(2018) Elizabeth J Samelson et al.   Lancet Diabetes & Endocrinology

Trabecular and Cortical Microstructure and Fragility of the Distal Radius in Women

(2015) Yohann Bala et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Fitting Linear Mixed-Effects Models Usinglme4

(2015) Douglas Bates et al.   Journal of Statistical Software

Androgens and prostate cancer; pathogenesis and deprivation therapy

(2013) Mathis Grossmann et al.   BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM

A new method of segmentation of compact-appearing, transitional and trabecular compartments and quantification of cortical porosity from high resolution peripheral quantitative computed tomographic images

(2013) R. Zebaze et al.   BONE

Cardiovascular risk and bone loss in men undergoing androgen deprivation therapy for non-metastatic prostate cancer: implementation of standardized management guidelines

(2013) A. S. Cheung et al.   Andrology

Influence of bone affinity on the skeletal distribution of fluorescently labeled bisphosphonates in vivo

(2012) Anke J Roelofs et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Bone density and structure in healthy postmenopausal women treated with exemestane for the primary prevention of breast cancer: a nested substudy of the MAP.3 randomised controlled trial

(2012) Angela M Cheung et al.   LANCET ONCOLOGY

Bisphosphonate therapy in patients under androgen deprivation therapy for prostate cancer: a systematic review and meta-analysis

(2011) A Serpa Neto et al.   PROSTATE CANCER AND PROSTATIC DISEASES

Equivalent deficits in bone mass of the vertebral body and posterior processes in women with vertebral fractures: Implications regarding the pathogenesis of spinal osteoporosis

(2010) Ego Seeman et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Microarchitectural deterioration of cortical and trabecular bone: Differing effects of denosumab and alendronate

(2010) Ego Seeman et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Structural Decay of Bone Microarchitecture in Men with Prostate Cancer Treated with Androgen Deprivation Therapy

(2010) E. J. Hamilton et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Intracortical remodelling and porosity in the distal radius and post-mortem femurs of women: a cross-sectional study

(2010) Roger MD Zebaze et al.   LANCET

Denosumab in Men Receiving Androgen-Deprivation Therapy for Prostate Cancer

(2009) Matthew R. Smith et al.   NEW ENGLAND JOURNAL OF MEDICINE

Zoledronic Acid for the Prevention of Bone Loss in Postmenopausal Women With Low Bone Mass

(2009) Michael McClung et al.   OBSTETRICS AND GYNECOLOGY

Toremifene Increases Bone Mineral Density in Men Receiving Androgen Deprivation Therapy for Prostate Cancer: Interim Analysis of a Multicenter Phase 3 Clinical Study

(2007) M.R. Smith et al.   JOURNAL OF UROLOGY